TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence

Primary ovarian cancer is responsive to treatment, but chemoresistant recurrent disease ensues in majority of patients. Recent compelling evidence demonstrates that a specific population of cancer cells, the cancer stem cells, initiates and sustains tumors. It is therefore possible that this cell po...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chefetz, Ilana, Alvero, Ayesha B., Holmberg, Jennie C., Lebowitz, Noah, Craveiro, Vinicius, Yang-Hartwich, Yang, Yin, Gang, Squillace, Lisa, Soteras, Marta Gurrea, Aldo, Paulomi, Mor, Gil
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3587452/
https://ncbi.nlm.nih.gov/pubmed/23324344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.23406
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items